The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Herrmann, N.
* Articles by Lanctôt, K. L.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Herrmann, N.
* Articles by Lanctôt, K. L.
Related Collections
* Geriatric Psychiatry
* Stroke
* Atypical Neuroleptics
Am J Psychiatry 161:1113-1115, June 2004
© 2004 American Psychiatric Association


Brief Report

Atypical Antipsychotics and Risk of Cerebrovascular Accidents

Nathan Herrmann, M.D., F.R.C.P.C., Muhammad Mamdani, Pharm.D., M.A., M.P.H., and Krista L. Lanctôt, Ph.D.

OBJECTIVE: Randomized controlled trials have suggested that at least one atypical antipsychotic may be associated with an increased risk of stroke in older people with dementia. This study examined the association between atypical antipsychotic use and stroke in the elderly. METHOD: The authors conducted a retrospective population-based cohort study of patients over the age of 66 by linking administrative health care databases. Three cohorts—users of typical antipsychotics, risperidone, and olanzapine—were identified and compared. RESULTS: Subjects treated with typical antipsychotics (N=1,015) were compared with those given risperidone (N=6,964) and olanzapine (N=3,421). Model-based estimates adjusted for covariates hypothesized to be associated with stroke risk revealed relative risk estimates of 1.1 (95% CI=0.5–2.3) for olanzapine and 1.4 (95% CI=0.7–2.8) for risperidone. CONCLUSIONS: Olanzapine and risperidone use were not associated with a statistically significant increased risk of stroke compared with typical antipsychotic use.




This article has been cited by other articles:


Home page
BMJHome page
I. J Douglas and L. Smeeth
Exposure to antipsychotics and risk of stroke: self controlled case series study
BMJ, August 28, 2008; 337(aug28_2): a1227 - a1227.
[Abstract] [Full Text] [PDF]


Home page
AJGPHome page
J. E. Streim, A. P. Porsteinsson, C. D. Breder, R. Swanink, R. Marcus, R. McQuade, and W. H. Carson
A Randomized, Double-Blind, Placebo-Controlled Study of Aripiprazole for the Treatment of Psychosis in Nursing Home Patients with Alzheimer Disease
Am J Geriatr Psychiatry, July 1, 2008; 16(7): 537 - 550.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
E. Sacchetti, G. Trifiro, A. Caputi, C. Turrina, E. Spina, C. Cricelli, O. Brignoli, E. Sessa, and G. Mazzaglia
Risk of stroke with typical and atypical anti-psychotics: a retrospective cohort study including unexposed subjects
J Psychopharmacol, January 1, 2008; 22(1): 39 - 46.
[Abstract] [PDF]


Home page
DTBHome page
How safe are antipsychotics in dementia?
DTB, November 1, 2007; 45(11): 81 - 85.
[Abstract] [Full Text] [PDF]


Home page
AJGPHome page
C. Ballard
Agitation and Psychosis in Dementia
Am J Geriatr Psychiatry, November 1, 2007; 15(11): 913 - 917.
[Full Text] [PDF]


Home page
AJGPHome page
J. E. Mintzer, L. E. Tune, C. D. Breder, R. Swanink, R. N. Marcus, R. D. McQuade, and A. Forbes
Aripiprazole for the Treatment of Psychoses in Institutionalized Patients With Alzheimer Dementia: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Assessment of Three Fixed Doses
Am J Geriatr Psychiatry, November 1, 2007; 15(11): 918 - 931.
[Abstract] [Full Text] [PDF]


Home page
AJGPHome page
J. Hollis, D. Grayson, L. Forrester, H. Brodaty, S. Touyz, and R. Cumming
Antipsychotic Medication Dispensing and Risk of Death in Veterans and War Widows 65 Years and Older
Am J Geriatr Psychiatry, November 1, 2007; 15(11): 932 - 941.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
H. C. Kales, M. Valenstein, H. M. Kim, J. F. McCarthy, D. Ganoczy, F. Cunningham, and F. C. Blow
Mortality Risk in Patients With Dementia Treated With Antipsychotics Versus Other Psychiatric Medications
Am J Psychiatry, October 1, 2007; 164(10): 1568 - 1576.
[Abstract] [Full Text] [PDF]


Home page
Journal of Pharmacy PracticeHome page
M. Malone, R. M. Carnahan, and E. C. Kutscher
Antipsychotic Medication Use in the Elderly Patient
Journal of Pharmacy Practice, August 1, 2007; 20(4): 318 - 326.
[Abstract] [PDF]


Home page
AJGPHome page
M. M. Raivio, J. V. Laurila, T. E. Strandberg, R. S. Tilvis, and K. H. Pitkala
Neither Atypical Nor Conventional Antipsychotics Increase Mortality or Hospital Admissions Among Elderly Patients With Dementia: A Two-Year Prospective Study
Am J Geriatr Psychiatry, May 1, 2007; 15(5): 416 - 424.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
T. L Bettinger, G. Shuler, D. R Jones, and J. P Wilson
Schizophrenia: Multi-Attribute Utility Theory Approach to Selection of Atypical Antipsychotics
Ann. Pharmacother., February 1, 2007; 41(2): 201 - 207.
[Abstract] [Full Text] [PDF]


Home page
PsychosomaticsHome page
D. A. Straker, P. A. Shapiro, and P. R. Muskin
Aripiprazole in the Treatment of Delirium
Psychosomatics, October 1, 2006; 47(5): 385 - 391.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Bull.Home page
K. L. Franks
Response to guidance on use of olanzapine and risperidone: a community-based study of primary and secondary care
Psychiatr. Bull., August 1, 2006; 30(8): 289 - 292.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
D. Layton, S. Harris, L. V. Wilton, and S. A. W. Shakir
Comparison of incidence rates of cerebrovascular accidents and transient ischaemic attacks in observational cohort studies of patients prescribed risperidone, quetiapine or olanzapine in general practice in England including patients with dementia
J Psychopharmacol, September 1, 2005; 19(5): 473 - 482.
[Abstract] [PDF]


Home page
Adv. Psychiatr. Treat.Home page
S. Karim and E. J. Byrne
Treatment of psychosis in elderly people
Advan. Psychiatr. Treat., July 1, 2005; 11(4): 286 - 296.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
C.-S. ZHAO, K. PUURUNEN, J. SIVENIUS, J. JOLKKONEN, and T. SCHALLERT
Psychotropic Medication and Stroke Outcome
Am J Psychiatry, May 1, 2005; 162(5): 1026 - 1027.
[Full Text] [PDF]


Home page
BMJHome page
S. S Gill, P. A Rochon, N. Herrmann, P. E Lee, K. Sykora, N. Gunraj, S.-L. T Normand, J. H Gurwitz, C. Marras, W. P Wodchis, et al.
Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study
BMJ, February 26, 2005; 330(7489): 445.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. NewsHome page
J. Rosack
Antipsychotics Do Not Appear To Increase Stroke Risk
Psychiatr News, July 16, 2004; 39(14): 22 - 23.
[Full Text]




Get information about faster international access.

Privacy Policy

Copyright © 2004 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org